TopFunds

Stryker Corporation

NYSE: SYK

Stock price

276.97 USD

(+0%) TODAY

Health Care EquipmentMedical - DevicesInvestable Universe
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3.8
4.4
2.7
9.3
5.5
4.2
5.2
6.2
8.3
7.8
8.4
8.3%
02Free cash flow per share
1.7
3.8
2.5
5.4
4.1
7.3
7.2
5.3
8.2
9
11.2
21.1%
03Dividends per share
1.4
1.6
1.7
1.9
2.1
2.4
2.6
2.8
3.1
3.2
3.4
9.2%
04Dividends payout, %
36.2%
34.5%
62.4%
19.8%
37.4%
54%
47.6%
44.6%
36%
40.7%
39.6%
0.9%
PROFIT AND LOSS STATEMENT
05Revenue
9,946
11,325
12,444
13,601
14,884
14,351
17,108
18,449
20,498
22,595
25,116
9.7%
06% Change
-
-
-
-
-
-
-
-
-
-
-
9.7%
07Cost of revenue
(3,559)
(4,079)
(4,541)
(5,001)
(5,502)
(5,598)
(6,399)
(7,409)
(8,004)
(8,615)
(9,051)
9.8%
08Gross profit
6,387
7,246
7,903
8,600
9,382
8,753
10,709
11,040
12,494
13,980
16,065
9.7%
09% Margin
64.2%
64%
63.5%
63.2%
63%
61%
62.6%
59.8%
61%
61.9%
64%
62.6% A
10Operating expenses
(4,135)
(4,669)
(5,136)
(5,496)
(5,994)
(5,725)
(6,946)
(7,306)
(8,213)
(8,919)
(11,176)
10.5%
11% of Revenue
(41.6)%
(41.2)%
(41.3)%
(40.4)%
(40.3)%
(39.9)%
(40.6)%
(39.6)%
(40.1)%
(39.5)%
(44.5)%
(40.8)% A
12Operating Income
2,252
2,577
2,767
3,104
3,388
3,028
3,763
3,734
4,281
5,061
4,889
8.1%
13Income tax expense
(296)
(274)
(1,043)
(1,197)
(479)
(355)
(287)
(325)
(508)
(499)
(1,268)
15.7%
14Net Income
1,439
1,647
1,020
3,553
2,083
1,599
1,994
2,358
3,165
2,993
3,246
8.5%
15% Margin
14.5%
14.5%
8.2%
26.1%
14%
11.1%
11.7%
12.8%
15.4%
13.3%
12.9%
14.1% A
16Shares Outstanding
380.9
378.5
380.1
380.3
379.9
380.3
382.3
382.2
383.7
385.6
382.2
-
17EPS Basic
3.8
4.4
2.7
9.5
5.6
4.3
5.3
6.2
8.3
7.9
8.5
8.3%
18EPS Diluted
3.8
4.4
2.7
9.3
5.5
4.2
5.2
6.2
8.3
7.8
8.4
8.3%
19EBITDA
2,240
2,695
2,952
3,343
3,627
3,081
3,608
4,018
5,057
4,938
6,314
10.9%
% Margin
22.5%
23.8%
23.7%
24.6%
24.4%
21.5%
21.1%
21.8%
24.7%
21.9%
25.1%
23.2% A
20Net Interest Income (expense)
(94)
(199)
(187)
(145)
(132)
(213)
(269)
(243)
(281)
(257)
(486)
17.9%
21Net Debt / EBITDA
0.3
1.3
1.6
1.9
2
3.7
2.8
2.9
2.1
2.1
2
2.1 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
3,379
3,316
2,542
3,616
4,337
2,943
2,944
1,844
2,971
3,652
4,011
1.7%
23Short-term investments
700
68
251
83
88
81
75
84
82
841
89
(18.6)%
24Accounts receivable
1,662
1,967
2,198
2,332
2,893
2,701
3,022
3,565
3,765
3,987
4,039
9.3%
25Other current assets
-
480
537
747
760
488
662
787
857
1,593
1,306
11.8%
26Inventory
1,639
2,030
2,465
2,955
3,282
3,494
3,314
3,995
4,843
4,774
5,310
12.5%
27Total Current Assets
7,944
7,861
7,993
9,733
11,360
9,707
10,017
10,275
12,518
14,847
14,755
6.4%
Non-Current Assets
28Net property, plant & equipment
1,199
1,569
1,975
2,291
2,951
3,175
3,252
3,443
3,709
3,964
4,395
13.9%
29Long-term investments
-
-
-
-
-
4
66
90
2
39
2
(12.9)%
30Other non-current assets
7,104
11,005
12,215
15,205
15,856
21,444
21,296
23,076
23,683
24,121
28,692
15%
31Total Non-Current Assets
8,303
12,574
14,190
17,496
18,807
24,623
24,614
26,609
27,394
28,124
33,089
14.8%
Total Assets
16,247
20,435
22,183
27,229
30,167
34,330
34,631
36,884
39,912
42,971
47,844
11.4%
LIABILITIES
Current Liabilities
32Accounts payable
410
437
487
646
675
810
1,129
1,413
1,517
1,679
1,799
15.9%
33Short-term debt
768
228
632
1,373
945
870
119
1,312
2,237
1,553
1,153
4.2%
34Other current liabilities
1,631
1,889
2,170
2,788
2,780
3,361
3,301
3,578
4,167
4,384
4,842
11.5%
35Total Current Liabilities
2,809
2,554
3,289
4,807
4,400
5,041
4,549
6,303
7,921
7,616
7,794
10.7%
Non-Current Liabilities
36Long-term debt
3,230
6,686
6,590
8,486
10,532
13,555
12,782
12,214
11,257
12,567
15,207
16.8%
37Other non-current liabilities
980
1,051
2,142
2,206
2,428
2,650
2,423
1,751
2,141
2,154
2,423
9.5%
38Total Non-Current Liabilities
4,210
7,737
8,732
10,692
12,960
16,205
15,205
13,965
13,398
14,721
17,630
15.4%
39Total Liabilities
7,712
10,885
12,217
15,499
17,360
21,246
19,754
20,268
21,319
22,337
25,424
12.7%
SHAREHOLDERS` EQUITY
40Common stock
37
37
37
37
37
38
38
38
38
38
38
0.3%
41Retained earnings / (deficit)
7,792
8,842
8,986
10,765
11,748
12,462
13,480
14,765
16,771
18,528
20,472
10.1%
42Accumulated other comprehensive income / (loss)
(639)
(761)
(553)
(631)
(606)
(1,157)
(531)
(221)
(416)
(293)
(687)
0.7%
43Noncontrolling interests
-
-
14
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
8,511
9,550
9,980
11,730
12,807
13,084
14,877
16,616
18,593
20,634
22,420
10.2%
45Total Liabilities and shareholders' Equity
16,247
20,435
22,183
27,229
30,167
34,330
34,631
36,884
39,912
42,971
47,844
11.4%
46Total Debt
3,998
6,914
7,222
9,859
11,477
14,425
12,901
13,526
13,494
14,120
16,360
15.1%
47Net Debt
619
3,598
4,680
6,243
7,140
11,482
9,957
11,682
10,523
10,468
12,349
34.9%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,439
1,647
1,020
3,553
2,083
1,599
1,994
2,358
3,165
2,993
3,246
8.5%
49Depreciation & amortization
397
546
642
723
778
812
990
998
1,028
1,050
1,193
11.6%
50Share-based compensation expense
86
97
113
119
127
142
171
168
205
229
243
11%
51Changes in working capital and other assets
(1,023)
(375)
(216)
(1,785)
(797)
724
108
(900)
(687)
(30)
362
-
52Net cash flows from operating activities
899
1,915
1,559
2,610
2,191
3,277
3,263
2,624
3,711
4,242
5,044
18.8%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(270)
(490)
(598)
(572)
(649)
(487)
(525)
(588)
(575)
(755)
(761)
10.9%
54Purchases of investments / marketable securities
(1,715)
(151)
(270)
(226)
(74)
(54)
(49)
(52)
(52)
(808)
-
(8)%
55Proceeds from maturities of marketable securities
4,094
785
87
394
69
61
55
240
54
148
750
(15.6)%
56Other investing activities
(153)
(4,335)
(832)
(2,453)
(801)
(4,221)
(340)
(2,524)
(389)
(1,585)
(4,855)
41.3%
57Net cash flows from investing activities
1,956
(4,191)
(1,613)
(2,857)
(1,455)
(4,701)
(859)
(2,924)
(962)
(3,000)
(4,866)
-
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(700)
(13)
(230)
(300)
(307)
(110)
(114)
(122)
(155)
(195)
(149)
(14.3)%
59Dividends paid, net
(521)
(568)
(636)
(703)
(778)
(863)
(950)
(1,051)
(1,139)
(1,219)
(1,284)
9.4%
60Debt issuance (repayments), net
48
2,912
299
2,456
1,293
989
(1,153)
472
(277)
940
1,579
41.8%
61Other financing activities
32
(73)
(227)
(124)
(205)
(27)
(148)
(48)
(23)
(51)
(33)
-
62Net cash flows from financing activities
(1,141)
2,258
(794)
1,329
3
(11)
(2,365)
(749)
(1,594)
(525)
113
-
63Increase (decrease) in cash and cash equivalents
1,584
(63)
(774)
1,074
721
(1,394)
1
(1,100)
1,127
681
359
(13.8)%
64Cash and equivalents, ending balance
3,379
3,316
2,542
3,616
4,337
2,943
2,944
1,844
2,971
3,652
4,011
1.7%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
629
1,425
961
2,038
1,542
2,790
2,738
2,036
3,136
3,487
4,283
21.2%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Stryker Corporation (SYK) financial statements and performance

Explore Stryker Corporation (SYK) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.